INMED PHARMACEUTICALS INC. Restricted Cash, Noncurrent
INMED PHARMACEUTICALS INC. (INM) had Restricted Cash, Noncurrent of $9.60 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2023-05-15
- 2023-03-31: Restricted Cash, Noncurrent $9.60M.
- 2022-12-31: Restricted Cash, Noncurrent $11.45M.
- 2022-09-30: Restricted Cash, Noncurrent $9.35M.
- 2022-06-30: Restricted Cash, Noncurrent $6.18M.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2023-03-31 | $9.60M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.45M 10-Q · filed 2023-02-17 |
| 2022-09-30 | $9.35M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.18M 10-K · filed 2022-09-23 |
| 2022-03-31 | $5.90M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $11.28M 10-Q · filed 2023-02-17 |
| 2021-09-30 | $15.34M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $7.36M 10-K · filed 2022-09-23 |
| 2021-03-31 | $9.45M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $10.02M 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |